NPM1 and acute myeloid leukemia: The use of PCR for MRD detection in AML offers more sensitivity (1 × 10−6) compared to MFC but is limited by the presence of targetable genetic abnormalities, and is currently primarily used in NPM1 mutated AML [9,52].